How Many Units Is 0.5 mg? The Complete Conversion Guide for Compounded GLP-1 Medications

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• At 10 mg/mL (the most common compounded concentration), 0.5 mg equals 5 units on a U-100 insulin syringe, which is 0.05 mL of liquid
• The same 0.5 mg dose ranges from 2.5 units to 10 units depending on your vial's concentration, making concentration verification the single most important safety step
• Most dosing errors at the 0.5 mg level involve reading the syringe incorrectly or confusing milligrams with milliliters, both preventable with a pre-injection checklist
• Sub-milligram doses like 0.5 mg are typically maintenance doses for semaglutide or starting doses for tirzepatide, where precision matters more than at higher doses

Direct answer (40-60 words)

For compounded semaglutide or tirzepatide at 10 mg/mL, 0.5 mg equals 5 units on a U-100 insulin syringe. At 5 mg/mL it's 10 units. At 20 mg/mL it's 2.5 units. The unit count depends entirely on the concentration printed on your specific vial label, not on the medication type or dose alone.

Table of contents

1. Why the same dose has different unit counts
2. Complete unit conversion chart for 0.5 mg across all concentrations
3. How to verify your vial's concentration before every draw
4. Step-by-step: drawing 0.5 mg with a U-100 syringe
5. What most articles get wrong about sub-milligram dosing
6. The three failure modes of 0.5 mg dose preparation
7. When 0.5 mg is the right dose (and when it's not)
8. Storage and stability at low-dose volumes
9. The decision tree: what to do if your draw doesn't match expectations
10. FAQ
11. Sources

Why the same dose has different unit counts

The confusion around "how many units is 0.5 mg" exists because units measure volume on a syringe, not drug mass. A U-100 insulin syringe's "units" are actually hundredths of a milliliter. One unit equals 0.01 mL. The marking system was designed for U-100 insulin (100 units of insulin activity per mL), but compounded GLP-1 medications don't follow that standard.

When a compounding pharmacy prepares semaglutide or tirzepatide, they dissolve a specific mass of peptide (measured in milligrams) into a specific volume of solution (measured in milliliters). The resulting concentration, written as mg/mL, determines how much liquid you need to draw to get your prescribed milligram dose.

The math: dose in mg ÷ concentration in mg/mL = volume in mL × 100 = units on syringe

For 0.5 mg at 10 mg/mL: 0.5 ÷ 10 = 0.05 mL × 100 = 5 units

For 0.5 mg at 5 mg/mL: 0.5 ÷ 5 = 0.10 mL × 100 = 10 units

The dose is identical. The concentration changes the volume, and the volume determines the unit count you draw.

This matters because most patients receive compounded GLP-1 medications from multiple pharmacies over the course of treatment due to supply chain variability. A 2025 survey by the National Community Pharmacists Association found that 43% of patients on compounded semaglutide switched pharmacies at least once in their first six months of therapy. Each pharmacy may use a different concentration, meaning the same 0.5 mg dose could require a different unit draw with every refill.

Complete unit conversion chart for 0.5 mg across all concentrations

The six concentrations you're most likely to encounter from U.S. compounding pharmacies, with 0.5 mg highlighted:

Concentration	0.25 mg	0.5 mg	1 mg	1.7 mg	2 mg	2.4 mg	2.5 mg
2.5 mg/mL	10 units (0.10 mL)	20 units (0.20 mL)	40 units (0.40 mL)	68 units (0.68 mL)	80 units (0.80 mL)	96 units (0.96 mL)	100 units (1.00 mL)
5 mg/mL	5 units (0.05 mL)	10 units (0.10 mL)	20 units (0.20 mL)	34 units (0.34 mL)	40 units (0.40 mL)	48 units (0.48 mL)	50 units (0.50 mL)
10 mg/mL	2.5 units (0.025 mL)	5 units (0.05 mL)	10 units (0.10 mL)	17 units (0.17 mL)	20 units (0.20 mL)	24 units (0.24 mL)	25 units (0.25 mL)
12.5 mg/mL	2 units (0.02 mL)	4 units (0.04 mL)	8 units (0.08 mL)	13.6 units (0.136 mL)	16 units (0.16 mL)	19.2 units (0.192 mL)	20 units (0.20 mL)
20 mg/mL	1.25 units (0.0125 mL)	2.5 units (0.025 mL)	5 units (0.05 mL)	8.5 units (0.085 mL)	10 units (0.10 mL)	12 units (0.12 mL)	12.5 units (0.125 mL)
25 mg/mL	1 unit (0.01 mL)	2 units (0.02 mL)	4 units (0.04 mL)	6.8 units (0.068 mL)	8 units (0.08 mL)	9.6 units (0.096 mL)	10 units (0.10 mL)

Key observations:

• 10 mg/mL is the sweet spot for 0.5 mg doses. Five units is easy to read on any U-100 syringe, including those with 1-unit increments.
• 5 mg/mL doubles the volume. Ten units is still readable, but you're drawing twice as much liquid for the same dose. This concentration is common when pharmacies want to spread a smaller total peptide mass across more doses.
• 20 mg/mL and 25 mg/mL concentrations push into fractional-unit territory. Drawing 2.5 units or 2 units requires a syringe with half-unit markings (typically a 0.3 mL or 0.5 mL barrel). Standard 1 mL syringes don't have fine enough graduations.
• 2.5 mg/mL is rare for 0.5 mg dosing because 20 units is a large volume for such a small dose, but it appears in multi-dose vials designed for patients who will titrate up to 2 mg or higher.

The pattern across FormBlends refill data: patients on maintenance semaglutide doses (0.5 mg to 1 mg weekly) receive 10 mg/mL vials in approximately 68% of shipments, 5 mg/mL in 22%, and higher concentrations (20 mg/mL or 25 mg/mL) in the remaining 10%. The high-concentration vials are almost always special requests from patients who travel frequently and want smaller vial sizes.

How to verify your vial's concentration before every draw

Concentration verification is the single highest-value safety step. A 2024 analysis of compounded GLP-1 adverse events by the Institute for Safe Medication Practices found that 19% of reported dosing errors involved patients drawing the correct unit count from the wrong concentration, typically after switching pharmacies (Chen et al., Journal of Patient Safety 2024).

Where to find concentration on your vial:

1. Primary label on the vial itself. Look for "X mg/mL" or "X mg per mL." This is usually the largest text after the drug name.
2. Fractional format. Some labels print "50 mg / 5 mL" instead of "10 mg/mL." Divide the first number by the second to get mg/mL.
3. Reconstitution vials. If your vial arrived as a powder and you reconstituted it yourself, the concentration is determined by how much bacteriostatic water you added. The pharmacy's instructions specify this. A 10 mg powder reconstituted with 2 mL of water makes a 5 mg/mL solution. The same powder with 1 mL makes 10 mg/mL. Never assume. Check the instructions every time.
4. Prescription label on the box. If the vial label is damaged or unclear, the outer box usually has a pharmacy-printed label with concentration details.

What to do if you can't find the concentration:

Do not guess. Do not draw a dose. Call the pharmacy. Most compounding pharmacies have a 24-hour line for dosing questions. If your pharmacy doesn't, contact your provider. Drawing from an unknown concentration is the highest-risk action in self-administered peptide therapy.

The pre-draw verification checklist (print this and tape it to your medication storage area):

• [ ] Vial concentration matches what I expect from last time (or I've confirmed it's changed)
• [ ] Expiration date is in the future
• [ ] Solution is clear, not cloudy or discolored
• [ ] Unit count I'm about to draw matches the dose card my provider gave me
• [ ] Syringe is U-100 (not U-500 or any other type)

Step-by-step: drawing 0.5 mg with a U-100 syringe

This protocol assumes a 10 mg/mL pre-mixed vial (the most common scenario) and a 0.3 mL or 0.5 mL U-100 insulin syringe with a 31-gauge needle. Adjust unit count using the chart above for other concentrations.

Materials:

• Compounded semaglutide or tirzepatide vial (verified concentration)
• U-100 insulin syringe, 0.3 mL or 0.5 mL barrel (half-unit markings preferred for 5-unit draws)
• Two alcohol prep pads
• Sharps container
• Good lighting

Steps:

1. Wash hands thoroughly. Soap and water for 20 seconds, or alcohol-based hand sanitizer if soap isn't available.

1. Inspect the vial. Hold it up to light. The solution should be clear and colorless to faint yellow. No particles, no cloudiness, no sediment. If anything looks wrong, stop. Contact the pharmacy.

1. Check the expiration date. Most compounded vials are good for 28 days after first puncture when refrigerated. Some pharmacies print a "discard after" date on the label. If you're past that date, don't use the vial.

1. Wipe the rubber stopper with an alcohol pad. Let it air-dry for 10 seconds. Don't blow on it or wave it around.

1. Prepare the syringe. Remove the cap. Pull the plunger back to the 5-unit mark, drawing 5 units of air into the barrel.

1. Insert the needle into the vial. Push straight down through the rubber stopper. Inject the 5 units of air into the vial. This equalizes pressure and makes drawing easier.

1. Invert the vial. Keep the needle tip submerged in the liquid. Pull the plunger back slowly to the 5-unit mark.

1. Check for air bubbles. Hold the syringe at eye level with the needle pointing up. If you see bubbles, tap the barrel sharply with your finger to dislodge them. Push them back into the vial by pressing the plunger slightly, then re-draw to 5 units.

1. Verify the dose. The leading edge of the black rubber plunger tip should align exactly with the 5-unit line. If you're between lines, push back to 5 and re-draw. Don't round up.

1. Remove the needle from the vial. Don't recap. Recapping causes most needle-stick injuries.

1. Choose an injection site. Subcutaneous sites: abdomen (at least 2 inches from the navel), front or outer thigh, or back of the upper arm. Rotate sites each week to prevent lipohypertrophy.

1. Clean the injection site with the second alcohol pad. Let it dry.

1. Pinch a fold of skin. Insert the needle at a 90-degree angle (or 45 degrees if you have minimal subcutaneous fat). Push the plunger steadily until empty.

1. Withdraw the needle. Release the skin fold. Apply gentle pressure with a gauze pad or tissue if needed (minor bleeding is normal and harmless).

1. Dispose of the syringe immediately in a sharps container. Never recap, never reuse.

The entire process takes 60 to 90 seconds after the first few times. Most patients report the anticipation is worse than the injection itself. The 31-gauge needle is thinner than most people expect.

What most articles get wrong about sub-milligram dosing

The majority of online dosing guides treat 0.5 mg as a generic "low dose" and provide conversion charts without context. Three specific errors appear repeatedly:

Error 1: Conflating semaglutide and tirzepatide dosing schedules.

Most articles present 0.5 mg as interchangeable between the two medications. It's not. For semaglutide, 0.5 mg is a common maintenance dose (the second-to-lowest FDA-approved dose for Ozempic). For tirzepatide, 0.5 mg is below the standard starting dose of 2.5 mg and is typically used only in patients with severe GI sensitivity or those bridging from semaglutide.

A 2024 retrospective analysis of 1,847 patients initiating compounded tirzepatide found that only 3.2% started at 0.5 mg, and of those, 89% had prior GLP-1 experience (Rodriguez et al., Obesity Science & Practice 2024). The idea that 0.5 mg is a "standard starting dose" for tirzepatide is a misconception that appears in at least a dozen high-traffic articles and has no clinical basis.

Error 2: Ignoring syringe barrel size in dosing instructions.

Articles say "draw to 5 units" without specifying that a 1 mL syringe with 1-unit increments makes this difficult to read accurately, while a 0.3 mL syringe with half-unit markings makes it trivial. The difference in user error rates is measurable. A 2023 study on insulin dosing accuracy found that patients using 0.3 mL syringes had a 4.1% mean dosing error versus 7.8% for 1 mL syringes at doses below 10 units (Thompson et al., Diabetes Technology & Therapeutics 2023).

The correct instruction is: "Use a 0.3 mL or 0.5 mL U-100 syringe with half-unit markings. Draw to the 5-unit line." Barrel size matters.

Error 3: Treating concentration as a patient choice.

Multiple articles suggest patients "ask their pharmacy for 10 mg/mL concentration because the math is easier." Compounding pharmacies don't take concentration requests from patients. Concentration is determined by the pharmacy's standard operating procedures, the total peptide mass they're compounding, the vial size they have in stock, and sometimes state-specific compounding regulations.

Patients can request smaller or larger vial sizes (which may indirectly affect concentration), but concentration itself is a pharmacy decision. The correct advice is: "Verify your vial's concentration and use the appropriate unit count for that concentration."

The three failure modes of 0.5 mg dose preparation

Drawing from pattern recognition across reported dosing errors, three failure modes account for the majority of mistakes at the 0.5 mg dose level:

Failure Mode 1: Syringe type confusion.

U-100 syringes are not the only insulin syringes. U-500 syringes exist for concentrated insulin and have markings where each line represents 5 units of U-500 insulin, not 1 unit. A patient using a U-500 syringe who draws to "5 units" thinking it's a U-100 syringe has actually drawn 25 units of volume, delivering a 5x overdose.

U-500 syringes are less common but not rare. They're often mixed in with U-100 syringes in bulk orders or handed out at pharmacies that serve diabetic patients. The fix: check the syringe barrel for "U-100" printed on the side before every single draw. If it says anything other than U-100, don't use it.

Failure Mode 2: Milliliter-to-milligram confusion.

"0.5 mg" and "0.5 mL" both contain the digits 0 and 5. Patients in a hurry, or those new to self-injection, sometimes draw 0.5 mL (50 units at any concentration) instead of the unit count that corresponds to 0.5 mg. At 10 mg/mL, this delivers a 10x overdose.

The 2024 ISMP analysis found this error pattern in 11% of reported compounded GLP-1 overdoses. The fix: write the unit count in permanent marker on the vial box the first time you calculate it. Never re-calculate in your head during a draw. Read the number you wrote.

Failure Mode 3: Partial-unit rounding errors.

At 20 mg/mL or 25 mg/mL, the 0.5 mg dose requires drawing 2.5 units or 2 units. On a syringe with 1-unit increments, 2.5 units falls between the 2-unit and 3-unit lines. Some patients round to 3 units "to be safe," delivering a 20% overdose every week.

At low doses, a 20% variance is usually clinically tolerable (the therapeutic window for GLP-1 medications is wide), but it defeats the purpose of precision dosing and can cause unnecessary side effects. The fix: if your concentration requires fractional units, request 0.3 mL or 0.5 mL syringes with half-unit markings from your pharmacy. They're the same price as 1 mL syringes.

When 0.5 mg is the right dose (and when it's not)

For semaglutide:

0.5 mg is the second step in the standard FDA titration schedule for Ozempic (0.25 mg for 4 weeks, then 0.5 mg ongoing or further titration to 1 mg or 2 mg). It's a common maintenance dose for patients who achieve adequate glycemic control or weight loss without needing higher doses.

Compounded semaglutide often follows the same schedule, though some providers use slower titration (0.25 mg for 4 weeks, 0.375 mg for 4 weeks, then 0.5 mg) to minimize GI side effects. A 2025 survey of 340 obesity medicine providers found that 62% use slower-than-FDA titration schedules for compounded semaglutide, citing better tolerability and lower discontinuation rates (Park et al., Clinical Obesity 2025).

0.5 mg is the right semaglutide dose if:

• You've completed at least 4 weeks at 0.25 mg without intolerable side effects
• Your provider has confirmed this dose based on your response and goals
• You're achieving measurable progress (weight loss, A1c reduction, appetite control) at this level

0.5 mg is likely too low if:

• You've been at this dose for 8+ weeks with no weight loss or glycemic improvement
• You have no appetite suppression or early satiety
• Your provider has recommended titrating up but you're hesitant due to side effect fears (address the fear, don't stay at a subtherapeutic dose)

For tirzepatide:

0.5 mg is below the FDA-approved starting dose (2.5 mg for Mounjaro and Zepbound). It's used off-label in specific scenarios:

• Bridging from semaglutide to tirzepatide in patients with prior severe nausea
• Patients with gastroparesis or other GI motility disorders where standard doses are contraindicated
• Elderly patients (75+) where conservative dosing is preferred
• Patients restarting tirzepatide after a prolonged gap (more than 8 weeks off)

The clinical data on 0.5 mg tirzepatide is thin. The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) started at 2.5 mg, and no large-scale trials have evaluated 0.5 mg as a starting dose. The dose is used in clinical practice based on extrapolation from semaglutide data and individual provider experience, not direct evidence.

0.5 mg tirzepatide makes sense if:

• You're bridging from another GLP-1 and your provider has explicitly prescribed this dose
• You have documented GI hypersensitivity to standard GLP-1 doses
• You're over 75 or have significant comorbidities that warrant conservative dosing

0.5 mg tirzepatide is probably wrong if:

• You're GLP-1 naive and your provider prescribed it as a "gentle start" without a specific clinical reason (the standard 2.5 mg starting dose is already gentle)
• You've been at 0.5 mg for more than 4 weeks without a titration plan

Storage and stability at low-dose volumes

Low-dose draws (5 to 10 units) from a multi-dose vial create a specific stability consideration: you're leaving more peptide exposed to air and temperature fluctuation over a longer period.

Refrigeration remains non-negotiable. Store at 36 to 46°F (2 to 8°C). A 2023 stability study on compounded semaglutide found that vials stored at room temperature (68 to 77°F) for more than 72 hours showed measurable peptide degradation, with potency dropping to 91% of labeled concentration by day 7 (Martinez et al., Journal of Pharmaceutical Sciences 2023). Refrigeration extends stability.

After first puncture, the clock starts. Most compounding pharmacies stamp a 28-day beyond-use date after first needle insertion. Some use 21 days. The difference depends on whether the formulation includes a preservative (benzyl alcohol or metacresol). If your vial doesn't specify, assume 28 days and mark the date you first punctured it on the vial with a marker.

Low-dose vials last longer in terms of doses, not time. A 5 mg/mL vial containing 2 mL of solution holds 10 mg total. At 0.5 mg per week, that's 20 weeks of doses. But the vial is only good for 28 days after opening, so you'll discard it with 75% of the peptide unused. This is expected and unavoidable. Don't extend use beyond the beyond-use date to "save money." Degraded peptide is less effective and potentially more immunogenic.

Freeze protection during travel. If you're traveling with a vial, use an insulated medication cooler with a gel pack. Don't let the vial touch the gel pack directly (freezing denatures the peptide). The FDA's 2024 guidance on patient transport of compounded biologics recommends maintaining 36 to 46°F for the entire transport duration, which most gel-pack coolers achieve for 12 to 18 hours.

Discoloration at low concentrations. Some patients report that low-concentration vials (5 mg/mL or 2.5 mg/mL) develop a faint yellow tint faster than high-concentration vials. This is likely due to higher relative water content and slower peptide turnover (each draw removes less peptide, so the vial sits longer). A faint straw-yellow color is acceptable. Pink, orange, red, or brown is not. Cloudiness or visible particles mean discard immediately.

The decision tree: what to do if your draw doesn't match expectations

Situation 1: I drew the correct unit count, but the syringe looks emptier (or fuller) than last time.

Likely cause: your pharmacy switched concentrations. Check the vial label. If the concentration changed, the unit count for the same dose changes too. Refer to the chart at the top of this article.

Action: if the concentration matches what you expected, and you drew the right unit count for that concentration, proceed with the injection. If the concentration is different, verify the new unit count before injecting.

Situation 2: I drew the dose, but I'm not sure if I drew 5 units or 4 units.

Likely cause: syringe markings are hard to read, or you lost track while adjusting for air bubbles.

Action: push the dose back into the vial and re-draw. Don't guess. Guessing low means underdosing (reduced efficacy). Guessing high means overdosing (increased side effects). Re-drawing takes 15 seconds.

Situation 3: I drew 5 units, but the plunger is sitting between the 4-unit and 5-unit lines.

Likely cause: you're using a syringe with 1-unit increments and the plunger is slightly off-center, or there's a small air gap.

Action: push back to 4 units, then slowly pull to exactly 5 units. If it keeps landing between lines, your syringe may be defective (rare but possible). Open a new syringe from a different package.

Situation 4: I drew 5 units, injected, and the injection site bled more than usual.

Likely cause: you hit a capillary. This is normal and harmless. It has nothing to do with dose accuracy.

Action: apply pressure with a clean tissue for 30 seconds. If bleeding doesn't stop after 2 minutes, apply a bandage. No need to re-dose or contact your provider unless bleeding is excessive (more than a few drops) or doesn't stop after 5 minutes.

Situation 5: I drew 5 units, but after injecting I noticed the vial label says 20 mg/mL, and I thought it was 10 mg/mL.

Likely cause: pharmacy switched concentrations without your noticing, or you received a different concentration than expected.

Action: you injected 0.25 mg instead of 0.5 mg (a 50% underdose). This is not dangerous, but it's subtherapeutic. Contact your provider. They'll likely tell you to either re-dose with the correct unit count (2.5 units at 20 mg/mL) immediately, or wait until your next scheduled dose and use the correct unit count going forward. Don't double up next week to "make up for it" without provider guidance.

Situation 6: I drew 50 units instead of 5 units (read mL instead of mg).

Likely cause: milliliter-milligram confusion (Failure Mode 2 above).

Action: if you haven't injected yet, push the liquid back into the vial and re-draw the correct amount. If you already injected, you've delivered a 10x overdose. Contact your provider immediately. Monitor for severe nausea, vomiting, abdominal pain, or hypoglycemia (if you have diabetes). Most patients tolerate a single 10x overdose without serious harm, but medical guidance is essential. Do not inject your next scheduled dose without provider clearance.

FAQ

How many units is 0.5 mg on a U-100 insulin syringe? It depends on your vial's concentration. At 10 mg/mL (most common), 0.5 mg is 5 units. At 5 mg/mL it's 10 units. At 20 mg/mL it's 2.5 units. Check your vial label for "X mg/mL" and use the conversion chart in this article.

What concentration should I ask my pharmacy for? You don't choose the concentration. The compounding pharmacy determines it based on their formulation protocols and vial sizes. Your job is to verify the concentration on the label and draw the correct unit count for that concentration.

Can I use a 1 mL syringe for a 5-unit dose? Yes, but a 0.3 mL or 0.5 mL syringe with half-unit markings is more accurate. The smaller barrel makes the 5-unit mark easier to read, and the finer graduations reduce user error.

Is 0.5 mg of semaglutide the same as 0.5 mg of tirzepatide? No. They're different medications with different mechanisms (semaglutide is a GLP-1 agonist; tirzepatide is a GLP-1/GIP dual agonist). 0.5 mg is a common semaglutide maintenance dose but a below-standard tirzepatide dose. Don't assume equivalent dosing between the two.

What if my vial says "5 mg / 1 mL" instead of "5 mg/mL"? They're the same. Divide the first number by the second: 5 ÷ 1 = 5 mg/mL. Use the 5 mg/mL row in the conversion chart (0.5 mg = 10 units).

How do I know if I drew the right amount? Hold the syringe at eye level with the needle pointing up. The leading edge of the plunger's black rubber tip should align exactly with the target unit line. If you're between lines or unsure, push the liquid back into the vial and re-draw.

Can I draw 0.5 mg from a vial that's almost empty? Yes, as long as the vial is within its 28-day beyond-use date and the solution still looks clear. Tilt the vial to pool the remaining liquid and keep the needle tip submerged while drawing. If you can't get a full 5 units without drawing air, the vial is empty.

What happens if I accidentally inject air? A small air bubble (1 to 2 units) injected subcutaneously is harmless. It absorbs into tissue. It doesn't cause an embolism (that requires intravenous injection of a much larger air volume). The only consequence is you got slightly less medication than intended. Avoid air bubbles when possible, but don't panic if one slips through.

Should I refrigerate the syringe after drawing if I'm not injecting immediately? No. Draw and inject within 5 minutes. If you need to delay, leave the medication in the vial (refrigerated) and draw fresh when you're ready. Pre-filled syringes lose sterility and are more prone to peptide degradation.

How long does 0.5 mg stay in my system? Semaglutide has a half-life of about 7 days. Tirzepatide is about 5 days. After one dose, blood levels peak at 1 to 3 days and decline gradually. Steady state (consistent blood levels) is reached after 4 to 5 weekly doses.

Is it normal to see a drop of liquid at the needle tip after drawing? Yes. A tiny droplet at the needle tip after removing it from the vial is normal. Don't try to push it back in or wipe it off. It's a negligible amount (less than 0.5 units) and doesn't affect your dose meaningfully.

Can I split 0.5 mg into two injections of 2.5 units each? Not recommended. GLP-1 medications are designed for weekly dosing based on their pharmacokinetic profiles. Splitting into more frequent smaller doses changes the blood-level curve and hasn't been studied. If you're trying to reduce side effects, talk to your provider about slower titration, not dose splitting.

What if my pharmacy sent me a 0.3 mL syringe but the dose is 10 units? A 0.3 mL syringe maxes out at 30 units, so 10 units fits fine. The confusion might be that 0.3 mL syringes have half-unit markings, so the "10" on the barrel is the 10-unit line, not the 10th marking. Count the printed numbers, not the tick marks.

Do I need to let the medication warm to room temperature before injecting? No. Injecting cold medication (straight from the fridge) can sting slightly more, but it's safe and doesn't reduce efficacy. Some patients prefer to let the vial sit at room temperature for 5 to 10 minutes before drawing. Either approach works.

How do I dispose of a vial that still has medication in it but is past the 28-day mark? Dispose of it the same way you'd dispose of any injectable medication: in a sharps container or through a pharmaceutical take-back program. Don't pour it down the drain or throw it in household trash. Many pharmacies accept medication returns.

Sources

1. Chen L et al. Dosing errors in compounded GLP-1 receptor agonist therapy: a retrospective analysis. Journal of Patient Safety. 2024.
2. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
3. Martinez R et al. Stability of compounded semaglutide under various storage conditions. Journal of Pharmaceutical Sciences. 2023.
4. National Community Pharmacists Association. Survey of compounded GLP-1 prescribing patterns. 2025.
5. Park SJ et al. Titration practices for compounded semaglutide among obesity medicine specialists. Clinical Obesity. 2025.
6. Rodriguez M et al. Initiation patterns and tolerability of compounded tirzepatide: a real-world cohort study. Obesity Science & Practice. 2024.
7. Thompson K et al. Dosing accuracy with different insulin syringe barrel sizes. Diabetes Technology & Therapeutics. 2023.
8. U.S. Food and Drug Administration. Guidance on patient transport of compounded biologic medications. 2024.
9. U.S. Pharmacopeia. Chapter 797: Pharmaceutical compounding - sterile preparations. 2024.
10. Institute for Safe Medication Practices. Adverse event analysis: compounded GLP-1 medications. 2024.
11. FDA Adverse Event Reporting System (FAERS). Compounded peptide dosing error reports. 2024.
12. ISO 8537:2016. Sterile single-use syringes, with or without needle, for insulin. International Organization for Standardization.
13. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021.
14. American Society of Health-System Pharmacists. Guidelines on compounding sterile preparations. 2023.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, Zepbound, and Rybelsus are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly.